Hepatitis C Virus in North Africa: An Emerging Threat

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/tswj/volume-2016/7370524/figures/7370524.fig.003a.svgz" name="7370524.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Libya</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/tswj/volume-2016/7370524/figures/7370524.fig.003b.svgz" name="7370524.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Egypt</td></tr></table>

<div>The impact of prevention and treatment on future prevalence rates of HCV. Modeled prevalence of hepatitis C virus infection Libya and Egypt. A: number of HCV-infected cases. B: number of cases after prevention. C: number of cases after prevention and treatment.</div>

The Scientific World Journal

fig3

Figure 3

Figure 3: Hepatitis C Virus in North Africa: An Emerging Threat 